Drug Development and Launch Timeline Analysis Across 6 High-Income Countries: From Pivotal Trial to HTA

This timeline analysis tracks the journey of drug development and market entry across six high-income countries, highlighting key milestones from pivotal trials to HTA submission and approval.

Presented at ISPOR EU 2024, Barcelona, Spain.

Please click here to download the poster. Don’t forget to subscribe to our newsletter below for the latest company updates, recently published HTA guidance, industry insights, and more!